Intrinsic Value of S&P & Nasdaq Contact Us

Annexon, Inc. ANNX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.00
+175.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Annexon, Inc. (ANNX) has a negative trailing P/E of -4.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 24.2 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -21.82%, forward earnings yield 4.13%. PEG 0.11 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.11); analyst target implies upside (+175.9%).
  • Forward P/E 24.2 — analysts expect a return to profitability with estimated EPS of $0.24 for FY2028.
  • PEG Ratio 0.11 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -21.82% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 4.13% as earnings recover.
  • Analyst consensus target $16.00 (+175.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 57/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
58/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
34/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — ANNX

Valuation Multiples
P/E (TTM)-4.6
Forward P/E24.2
PEG Ratio0.11
Forward PEG0.11
P/B Ratio4.48
P/S Ratio0.00
EV/EBITDA-2.8
Per Share Data
EPS (TTM)$-1.33
Forward EPS (Est.)$0.24
Book Value / Share$1.36
Revenue / Share$0.00
FCF / Share$-1.20
Yields & Fair Value
Earnings Yield-21.82%
Forward Earnings Yield4.13%
Dividend Yield0.00%
Analyst Target$16.00 (+175.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2017 -36.3 0.00 -14.69 0.00 -
2018 -11.1 -0.05 5.37 0.00 -
2019 -18.3 0.46 15.59 0.00 -
2020 -6.7 -0.02 1.23 0.00 1.46%
2021 -3.4 0.35 1.90 0.00 -
2022 -2.0 0.09 1.22 0.00 -
2023 -2.6 0.08 1.37 0.00 -
2024 -5.1 0.12 2.40 0.00 -
2025 -3.8 -0.12 3.68 0.00 0.24%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2017 $-0.49 $0.00 $-18.71M -
2018 $-1.60 $0.00 $-18.3M -
2019 $-0.97 $0.00 $-37.18M -
2020 $-3.70 $0.00 $-62.75M -
2021 $-3.34 $0.00 $-127.79M -
2022 $-2.53 $0.00 $-138.3M -
2023 $-1.77 $0.00 $-134.24M -
2024 $-1.01 $0.00 $-138.2M -
2025 $-1.34 $0.00 $-206.69M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.05 $-1.25 – $-0.91 $2.36M $409.61K – $5.67M 6
2027 $-0.79 $-1.00 – $-0.37 $55.92M $11.28M – $132.85M 6
2028 $0.17 $-0.45 – $1.04 $324.34M $316.03M – $332.64M 5
2029 $1.02 $-0.08 – $2.87 $612.06M $106.12M – $1.47B 1
2030 $2.61 $-0.19 – $7.37 $1.06B $183.91M – $2.55B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message